This pipeline uses various statistical tests to identify selected clinical features related to mutation rate.
Testing the association between 2 variables and 40 clinical features across 194 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 8 clinical features related to at least one variables.
-
2 variables correlated to 'AGE'.
-
MUTATIONRATE_SILENT , MUTATIONRATE_NONSYNONYMOUS
-
2 variables correlated to 'AGE_mutation.rate'.
-
MUTATIONRATE_NONSYNONYMOUS , MUTATIONRATE_SILENT
-
2 variables correlated to 'NUMBER_PACK_YEARS_SMOKED'.
-
MUTATIONRATE_NONSYNONYMOUS , MUTATIONRATE_SILENT
-
2 variables correlated to 'TOBACCO_SMOKING_PACK_YEARS_SMOKED'.
-
MUTATIONRATE_NONSYNONYMOUS , MUTATIONRATE_SILENT
-
2 variables correlated to 'MENOPAUSE_STATUS'.
-
MUTATIONRATE_SILENT , MUTATIONRATE_NONSYNONYMOUS
-
1 variable correlated to 'KERATINIZATION_SQUAMOUS_CELL'.
-
MUTATIONRATE_SILENT
-
1 variable correlated to 'INITIAL_PATHOLOGIC_DX_YEAR'.
-
MUTATIONRATE_SILENT
-
2 variables correlated to 'AGE_AT_DIAGNOSIS'.
-
MUTATIONRATE_SILENT , MUTATIONRATE_NONSYNONYMOUS
-
No variables correlated to 'DAYS_TO_DEATH_OR_LAST_FUP', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', 'NUMBER_OF_LYMPH_NODES', 'RACE', 'ETHNICITY', 'WEIGHT_KG_AT_DIAGNOSIS', 'TUMOR_STATUS', 'NEOPLASM_HISTOLOGIC_GRADE', 'TOBACCO_SMOKING_YEAR_STOPPED', 'TOBACCO_SMOKING_HISTORY', 'AGEBEGANSMOKINGINYEARS', 'RADIATION_THERAPY_STATUS', 'PREGNANCIES_COUNT_TOTAL', 'PREGNANCIES_COUNT_STILLBIRTH', 'PREGNANCY_SPONTANEOUS_ABORTION_COUNT', 'PREGNANCIES_COUNT_LIVE_BIRTH', 'PREGNANCY_THERAPEUTIC_ABORTION_COUNT', 'PREGNANCIES_COUNT_ECTOPIC', 'POS_LYMPH_NODE_LOCATION', 'LYMPHOVASCULAR_INVOLVEMENT', 'LYMPH_NODES_EXAMINED_HE_COUNT', 'LYMPH_NODES_EXAMINED', 'HISTORY_HORMONAL_CONTRACEPTIVES_USE', 'HEIGHT_CM_AT_DIAGNOSIS', 'CORPUS_INVOLVEMENT', 'CHEMO_CONCURRENT_TYPE', 'CERVIX_SUV_RESULTS', and 'CLINICAL_STAGE'.
Complete statistical result table is provided in Supplement Table 1
Table 1. Get Full Table This table shows the clinical features, statistical methods used, and the number of variables that are significantly associated with each clinical feature at P value < 0.05 and Q value < 0.3.
Clinical feature | Statistical test | Significant variables | Associated with | Associated with | ||
---|---|---|---|---|---|---|
DAYS_TO_DEATH_OR_LAST_FUP | Cox regression test | N=0 | ||||
AGE | Spearman correlation test | N=2 | older | N=2 | younger | N=0 |
AGE | Linear Regression Analysis | N=2 | ||||
PATHOLOGY_T_STAGE | Spearman correlation test | N=0 | ||||
PATHOLOGY_N_STAGE | Wilcoxon test | N=0 | ||||
PATHOLOGY_M_STAGE | Wilcoxon test | N=0 | ||||
RADIATION_THERAPY | Wilcoxon test | N=0 | ||||
HISTOLOGICAL_TYPE | Kruskal-Wallis test | N=0 | ||||
NUMBER_PACK_YEARS_SMOKED | Spearman correlation test | N=2 | higher number_pack_years_smoked | N=2 | lower number_pack_years_smoked | N=0 |
NUMBER_OF_LYMPH_NODES | Spearman correlation test | N=0 | ||||
RACE | Kruskal-Wallis test | N=0 | ||||
ETHNICITY | Wilcoxon test | N=0 | ||||
WEIGHT_KG_AT_DIAGNOSIS | Spearman correlation test | N=0 | ||||
TUMOR_STATUS | Wilcoxon test | N=0 | ||||
NEOPLASM_HISTOLOGIC_GRADE | Kruskal-Wallis test | N=0 | ||||
TOBACCO_SMOKING_YEAR_STOPPED | Spearman correlation test | N=0 | ||||
TOBACCO_SMOKING_PACK_YEARS_SMOKED | Spearman correlation test | N=2 | higher tobacco_smoking_pack_years_smoked | N=2 | lower tobacco_smoking_pack_years_smoked | N=0 |
TOBACCO_SMOKING_HISTORY | Spearman correlation test | N=0 | ||||
AGEBEGANSMOKINGINYEARS | Spearman correlation test | N=0 | ||||
RADIATION_THERAPY_STATUS | Wilcoxon test | N=0 | ||||
PREGNANCIES_COUNT_TOTAL | Spearman correlation test | N=0 | ||||
PREGNANCIES_COUNT_STILLBIRTH | Spearman correlation test | N=0 | ||||
PREGNANCY_SPONTANEOUS_ABORTION_COUNT | Spearman correlation test | N=0 | ||||
PREGNANCIES_COUNT_LIVE_BIRTH | Spearman correlation test | N=0 | ||||
PREGNANCY_THERAPEUTIC_ABORTION_COUNT | Spearman correlation test | N=0 | ||||
PREGNANCIES_COUNT_ECTOPIC | Spearman correlation test | N=0 | ||||
POS_LYMPH_NODE_LOCATION | Kruskal-Wallis test | N=0 | ||||
MENOPAUSE_STATUS | Kruskal-Wallis test | N=2 | ||||
LYMPHOVASCULAR_INVOLVEMENT | Wilcoxon test | N=0 | ||||
LYMPH_NODES_EXAMINED_HE_COUNT | Spearman correlation test | N=0 | ||||
LYMPH_NODES_EXAMINED | Spearman correlation test | N=0 | ||||
KERATINIZATION_SQUAMOUS_CELL | Wilcoxon test | N=1 | non-keratinizing squamous cell carcinoma | N=1 | keratinizing squamous cell carcinoma | N=0 |
INITIAL_PATHOLOGIC_DX_YEAR | Spearman correlation test | N=1 | higher initial_pathologic_dx_year | N=0 | lower initial_pathologic_dx_year | N=1 |
HISTORY_HORMONAL_CONTRACEPTIVES_USE | Kruskal-Wallis test | N=0 | ||||
HEIGHT_CM_AT_DIAGNOSIS | Spearman correlation test | N=0 | ||||
CORPUS_INVOLVEMENT | Wilcoxon test | N=0 | ||||
CHEMO_CONCURRENT_TYPE | Kruskal-Wallis test | N=0 | ||||
CERVIX_SUV_RESULTS | Spearman correlation test | N=0 | ||||
AGE_AT_DIAGNOSIS | Spearman correlation test | N=2 | higher age_at_diagnosis | N=2 | lower age_at_diagnosis | N=0 |
CLINICAL_STAGE | Kruskal-Wallis test | N=0 |
No variable related to 'DAYS_TO_DEATH_OR_LAST_FUP'.
Table S1. Basic characteristics of clinical feature: 'DAYS_TO_DEATH_OR_LAST_FUP'
DAYS_TO_DEATH_OR_LAST_FUP | Duration (Months) | 0.1-210.7 (median=23.8) |
censored | N = 151 | |
death | N = 42 | |
Significant variables | N = 0 |
Table S2. Basic characteristics of clinical feature: 'AGE'
AGE | Mean (SD) | 47.29 (13) |
Significant variables | N = 2 | |
pos. correlated | 2 | |
neg. correlated | 0 |
Table S3. Get Full Table List of 2 variables significantly correlated to 'AGE' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
MUTATIONRATE_SILENT | 0.3242 | 4.481e-06 | 8.96e-06 |
MUTATIONRATE_NONSYNONYMOUS | 0.314 | 9.175e-06 | 9.17e-06 |
Table S4. Basic characteristics of clinical feature: 'AGE'
AGE | Mean (SD) | 47.29 (13) |
Significant variables | N = 2 |
Table S5. Get Full Table List of 2 variables significantly correlated to 'AGE' by Linear regression analysis [lm (mutation rate ~ age)]. Compared to a correlation analysis testing for interdependence of the variables, a regression model attempts to describe the dependence of a variable on one (or more) explanatory variables assuming that there is a one-way causal effect from the explanatory variable(s) to the response variable. If 'Residuals vs Fitted' plot (a standard residual plot) shows a random pattern indicating a good fit for a linear model, it explains linear regression relationship between Mutation rate and age factor. Adj.R-squared (= Explained variation / Total variation) indicates regression model's explanatory power.
Adj.R.squared | F | P | Residual.std.err | DF | coef(intercept) | coef.p(intercept) | |
---|---|---|---|---|---|---|---|
MUTATIONRATE_NONSYNONYMOUS | 0.0236 | 5.61 | 0.0189 | 7.13e-06 | 190 | 9.23e-08 ( -3.38e-07 ) | 0.0189 ( 0.86 ) |
MUTATIONRATE_SILENT | 0.0225 | 5.39 | 0.0213 | 2.08e-06 | 190 | 2.64e-08 ( 1.24e-08 ) | 0.0213 ( 0.982 ) |
Table S6. Basic characteristics of clinical feature: 'PATHOLOGY_T_STAGE'
PATHOLOGY_T_STAGE | Mean (SD) | 1.35 (0.59) |
N | ||
T1 | 104 | |
T2 | 40 | |
T3 | 3 | |
T4 | 2 | |
Significant variables | N = 0 |
Table S7. Basic characteristics of clinical feature: 'PATHOLOGY_N_STAGE'
PATHOLOGY_N_STAGE | Labels | N |
N0 | 95 | |
N1 | 44 | |
Significant variables | N = 0 |
Table S8. Basic characteristics of clinical feature: 'PATHOLOGY_M_STAGE'
PATHOLOGY_M_STAGE | Labels | N |
class0 | 79 | |
class1 | 4 | |
Significant variables | N = 0 |
Table S9. Basic characteristics of clinical feature: 'RADIATION_THERAPY'
RADIATION_THERAPY | Labels | N |
NO | 40 | |
YES | 52 | |
Significant variables | N = 0 |
Table S10. Basic characteristics of clinical feature: 'HISTOLOGICAL_TYPE'
HISTOLOGICAL_TYPE | Labels | N |
ADENOSQUAMOUS | 4 | |
CERVICAL SQUAMOUS CELL CARCINOMA | 158 | |
ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | 5 | |
ENDOCERVICAL TYPE OF ADENOCARCINOMA | 21 | |
ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | 2 | |
MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE | 4 | |
Significant variables | N = 0 |
Table S11. Basic characteristics of clinical feature: 'NUMBER_PACK_YEARS_SMOKED'
NUMBER_PACK_YEARS_SMOKED | Mean (SD) | 18.65 (12) |
Significant variables | N = 2 | |
pos. correlated | 2 | |
neg. correlated | 0 |
Table S12. Get Full Table List of 2 variables significantly correlated to 'NUMBER_PACK_YEARS_SMOKED' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
MUTATIONRATE_NONSYNONYMOUS | 0.3788 | 0.003666 | 0.00733 |
MUTATIONRATE_SILENT | 0.3446 | 0.008671 | 0.00867 |
Table S13. Basic characteristics of clinical feature: 'NUMBER_OF_LYMPH_NODES'
NUMBER_OF_LYMPH_NODES | Mean (SD) | 1.02 (2.2) |
Significant variables | N = 0 |
Table S14. Basic characteristics of clinical feature: 'RACE'
RACE | Labels | N |
AMERICAN INDIAN OR ALASKA NATIVE | 8 | |
ASIAN | 19 | |
BLACK OR AFRICAN AMERICAN | 16 | |
NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | 1 | |
WHITE | 138 | |
Significant variables | N = 0 |
Table S15. Basic characteristics of clinical feature: 'ETHNICITY'
ETHNICITY | Labels | N |
HISPANIC OR LATINO | 14 | |
NOT HISPANIC OR LATINO | 135 | |
Significant variables | N = 0 |
Table S16. Basic characteristics of clinical feature: 'WEIGHT_KG_AT_DIAGNOSIS'
WEIGHT_KG_AT_DIAGNOSIS | Mean (SD) | 75.87 (22) |
Significant variables | N = 0 |
Table S17. Basic characteristics of clinical feature: 'TUMOR_STATUS'
TUMOR_STATUS | Labels | N |
TUMOR FREE | 139 | |
WITH TUMOR | 45 | |
Significant variables | N = 0 |
No variable related to 'NEOPLASM_HISTOLOGIC_GRADE'.
Table S18. Basic characteristics of clinical feature: 'NEOPLASM_HISTOLOGIC_GRADE'
NEOPLASM_HISTOLOGIC_GRADE | Labels | N |
G1 | 14 | |
G2 | 88 | |
G3 | 82 | |
G4 | 1 | |
GX | 8 | |
Significant variables | N = 0 |
No variable related to 'TOBACCO_SMOKING_YEAR_STOPPED'.
Table S19. Basic characteristics of clinical feature: 'TOBACCO_SMOKING_YEAR_STOPPED'
TOBACCO_SMOKING_YEAR_STOPPED | Mean (SD) | 1998.93 (12) |
Significant variables | N = 0 |
2 variables related to 'TOBACCO_SMOKING_PACK_YEARS_SMOKED'.
Table S20. Basic characteristics of clinical feature: 'TOBACCO_SMOKING_PACK_YEARS_SMOKED'
TOBACCO_SMOKING_PACK_YEARS_SMOKED | Mean (SD) | 18.65 (12) |
Significant variables | N = 2 | |
pos. correlated | 2 | |
neg. correlated | 0 |
Table S21. Get Full Table List of 2 variables significantly correlated to 'TOBACCO_SMOKING_PACK_YEARS_SMOKED' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
MUTATIONRATE_NONSYNONYMOUS | 0.3788 | 0.003666 | 0.00733 |
MUTATIONRATE_SILENT | 0.3446 | 0.008671 | 0.00867 |
Table S22. Basic characteristics of clinical feature: 'TOBACCO_SMOKING_HISTORY'
TOBACCO_SMOKING_HISTORY | Mean (SD) | 1.82 (1.1) |
Value | N | |
1 | 93 | |
2 | 37 | |
3 | 8 | |
4 | 26 | |
5 | 1 | |
Significant variables | N = 0 |
Table S23. Basic characteristics of clinical feature: 'AGEBEGANSMOKINGINYEARS'
AGEBEGANSMOKINGINYEARS | Mean (SD) | 21.37 (7.4) |
Significant variables | N = 0 |
No variable related to 'RADIATION_THERAPY_STATUS'.
Table S24. Basic characteristics of clinical feature: 'RADIATION_THERAPY_STATUS'
RADIATION_THERAPY_STATUS | Labels | N |
COMPLETED AS PLANNED | 26 | |
TREATMENT NOT COMPLETED | 3 | |
Significant variables | N = 0 |
Table S25. Basic characteristics of clinical feature: 'PREGNANCIES_COUNT_TOTAL'
PREGNANCIES_COUNT_TOTAL | Mean (SD) | 3.41 (2.4) |
Significant variables | N = 0 |
No variable related to 'PREGNANCIES_COUNT_STILLBIRTH'.
Table S26. Basic characteristics of clinical feature: 'PREGNANCIES_COUNT_STILLBIRTH'
PREGNANCIES_COUNT_STILLBIRTH | Mean (SD) | 0.08 (0.37) |
Value | N | |
0 | 95 | |
1 | 5 | |
3 | 1 | |
Significant variables | N = 0 |
No variable related to 'PREGNANCY_SPONTANEOUS_ABORTION_COUNT'.
Table S27. Basic characteristics of clinical feature: 'PREGNANCY_SPONTANEOUS_ABORTION_COUNT'
PREGNANCY_SPONTANEOUS_ABORTION_COUNT | Mean (SD) | 0.31 (0.57) |
Value | N | |
0 | 81 | |
1 | 25 | |
2 | 3 | |
3 | 1 | |
Significant variables | N = 0 |
No variable related to 'PREGNANCIES_COUNT_LIVE_BIRTH'.
Table S28. Basic characteristics of clinical feature: 'PREGNANCIES_COUNT_LIVE_BIRTH'
PREGNANCIES_COUNT_LIVE_BIRTH | Mean (SD) | 2.4 (1.7) |
Significant variables | N = 0 |
No variable related to 'PREGNANCY_THERAPEUTIC_ABORTION_COUNT'.
Table S29. Basic characteristics of clinical feature: 'PREGNANCY_THERAPEUTIC_ABORTION_COUNT'
PREGNANCY_THERAPEUTIC_ABORTION_COUNT | Mean (SD) | 0.88 (1.9) |
Significant variables | N = 0 |
No variable related to 'PREGNANCIES_COUNT_ECTOPIC'.
Table S30. Basic characteristics of clinical feature: 'PREGNANCIES_COUNT_ECTOPIC'
PREGNANCIES_COUNT_ECTOPIC | Mean (SD) | 0.11 (0.34) |
Value | N | |
0 | 93 | |
1 | 9 | |
2 | 1 | |
Significant variables | N = 0 |
Table S31. Basic characteristics of clinical feature: 'POS_LYMPH_NODE_LOCATION'
POS_LYMPH_NODE_LOCATION | Labels | N |
MACROSCOPIC PARAMETRIAL INVOLVEMENT | 1 | |
MICROSCOPIC PARAMETRIAL INVOLVEMENT | 7 | |
OTHER LOCATION, SPECIFY | 30 | |
POSITIVE BLADDER MARGIN | 1 | |
POSITIVE VAGINAL MARGIN | 8 | |
Significant variables | N = 0 |
Table S32. Basic characteristics of clinical feature: 'MENOPAUSE_STATUS'
MENOPAUSE_STATUS | Labels | N |
INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) | 3 | |
PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) | 10 | |
POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) | 60 | |
PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) | 88 | |
Significant variables | N = 2 |
Table S33. Get Full Table List of 2 variables differentially expressed by 'MENOPAUSE_STATUS'
kruskal_wallis_P | Q | |
---|---|---|
MUTATIONRATE_SILENT | 4.944e-05 | 9.89e-05 |
MUTATIONRATE_NONSYNONYMOUS | 0.0007629 | 0.000763 |
No variable related to 'LYMPHOVASCULAR_INVOLVEMENT'.
Table S34. Basic characteristics of clinical feature: 'LYMPHOVASCULAR_INVOLVEMENT'
LYMPHOVASCULAR_INVOLVEMENT | Labels | N |
ABSENT | 63 | |
PRESENT | 67 | |
Significant variables | N = 0 |
No variable related to 'LYMPH_NODES_EXAMINED_HE_COUNT'.
Table S35. Basic characteristics of clinical feature: 'LYMPH_NODES_EXAMINED_HE_COUNT'
LYMPH_NODES_EXAMINED_HE_COUNT | Mean (SD) | 1.02 (2.2) |
Significant variables | N = 0 |
Table S36. Basic characteristics of clinical feature: 'LYMPH_NODES_EXAMINED'
LYMPH_NODES_EXAMINED | Mean (SD) | 21.56 (13) |
Significant variables | N = 0 |
One variable related to 'KERATINIZATION_SQUAMOUS_CELL'.
Table S37. Basic characteristics of clinical feature: 'KERATINIZATION_SQUAMOUS_CELL'
KERATINIZATION_SQUAMOUS_CELL | Labels | N |
KERATINIZING SQUAMOUS CELL CARCINOMA | 39 | |
NON-KERATINIZING SQUAMOUS CELL CARCINOMA | 86 | |
Significant variables | N = 1 | |
Higher in NON-KERATINIZING SQUAMOUS CELL CARCINOMA | 1 | |
Higher in KERATINIZING SQUAMOUS CELL CARCINOMA | 0 |
Table S38. Get Full Table List of one variable differentially expressed by 'KERATINIZATION_SQUAMOUS_CELL'
W(pos if higher in 'NON-KERATINIZING SQUAMOUS CELL CARCINOMA') | wilcoxontestP | Q | AUC | |
---|---|---|---|---|
MUTATIONRATE_SILENT | 1290.5 | 0.03964 | 0.0773 | 0.6152 |
One variable related to 'INITIAL_PATHOLOGIC_DX_YEAR'.
Table S39. Basic characteristics of clinical feature: 'INITIAL_PATHOLOGIC_DX_YEAR'
INITIAL_PATHOLOGIC_DX_YEAR | Mean (SD) | 2007.66 (5.1) |
Significant variables | N = 1 | |
pos. correlated | 0 | |
neg. correlated | 1 |
Table S40. Get Full Table List of one variable significantly correlated to 'INITIAL_PATHOLOGIC_DX_YEAR' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
MUTATIONRATE_SILENT | -0.1498 | 0.03805 | 0.0656 |
No variable related to 'HISTORY_HORMONAL_CONTRACEPTIVES_USE'.
Table S41. Basic characteristics of clinical feature: 'HISTORY_HORMONAL_CONTRACEPTIVES_USE'
HISTORY_HORMONAL_CONTRACEPTIVES_USE | Labels | N |
CURRENT USER | 8 | |
FORMER USER | 43 | |
NEVER USED | 46 | |
Significant variables | N = 0 |
Table S42. Basic characteristics of clinical feature: 'HEIGHT_CM_AT_DIAGNOSIS'
HEIGHT_CM_AT_DIAGNOSIS | Mean (SD) | 162.15 (6.6) |
Significant variables | N = 0 |
Table S43. Basic characteristics of clinical feature: 'CORPUS_INVOLVEMENT'
CORPUS_INVOLVEMENT | Labels | N |
ABSENT | 88 | |
PRESENT | 16 | |
Significant variables | N = 0 |
Table S44. Basic characteristics of clinical feature: 'CHEMO_CONCURRENT_TYPE'
CHEMO_CONCURRENT_TYPE | Labels | N |
CARBOPLATIN | 4 | |
CISPLATIN | 53 | |
OTHER | 1 | |
Significant variables | N = 0 |
Table S45. Basic characteristics of clinical feature: 'CERVIX_SUV_RESULTS'
CERVIX_SUV_RESULTS | Mean (SD) | 11.79 (3.8) |
Significant variables | N = 0 |
Table S46. Basic characteristics of clinical feature: 'AGE_AT_DIAGNOSIS'
AGE_AT_DIAGNOSIS | Mean (SD) | 47.42 (13) |
Significant variables | N = 2 | |
pos. correlated | 2 | |
neg. correlated | 0 |
Table S47. Get Full Table List of 2 variables significantly correlated to 'AGE_AT_DIAGNOSIS' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
MUTATIONRATE_SILENT | 0.3308 | 2.459e-06 | 4.82e-06 |
MUTATIONRATE_NONSYNONYMOUS | 0.3216 | 4.823e-06 | 4.82e-06 |
Table S48. Basic characteristics of clinical feature: 'CLINICAL_STAGE'
CLINICAL_STAGE | Labels | N |
STAGE I | 4 | |
STAGE IA | 1 | |
STAGE IA1 | 1 | |
STAGE IA2 | 1 | |
STAGE IB | 28 | |
STAGE IB1 | 53 | |
STAGE IB2 | 29 | |
STAGE II | 4 | |
STAGE IIA | 6 | |
STAGE IIA1 | 5 | |
STAGE IIA2 | 7 | |
STAGE IIB | 14 | |
STAGE III | 1 | |
STAGE IIIB | 29 | |
STAGE IVA | 2 | |
STAGE IVB | 5 | |
Significant variables | N = 0 |
-
Expresson data file = CESC-TP.patients.counts_and_rates.txt
-
Clinical data file = CESC-TP.merged_data.txt
-
Number of patients = 194
-
Number of variables = 2
-
Number of clinical features = 40
-
Further details on clinical features selected for this analysis, please find a documentation on selected CDEs (Clinical Data Elements). The first column of the file is a formula to convert values and the second column is a clinical parameter name.
-
There are also useful links about clinical features.
-
Survival time data
-
Survival time data is a combined value of days_to_death and days_to_last_followup. For each patient, it creates a combined value 'days_to_death_or_last_fup' using conversion process below.
-
if 'vital_status'==1(dead), 'days_to_last_followup' is always NA. Thus, uses 'days_to_death' value for 'days_to_death_or_fup'
-
if 'vital_status'==0(alive),
-
if 'days_to_death'==NA & 'days_to_last_followup'!=NA, uses 'days_to_last_followup' value for 'days_to_death_or_fup'
-
if 'days_to_death'!=NA, excludes this case in survival analysis and report the case.
-
if 'vital_status'==NA,excludes this case in survival analysis and report the case.
-
cf. In certain diesase types such as SKCM, days_to_death parameter is replaced with time_from_specimen_dx or time_from_specimen_procurement_to_death .
-
This analysis excluded clinical variables that has only NA values.
For survival clinical features, logrank test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values comparing quantile intervals using the 'coxph' function in R. Kaplan-Meier survival curves were plotted using quantile intervals at c(0, 0.25, 0.50, 0.75, 1). If there is only one interval group, it will not try survival analysis.
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For two groups (mutant or wild-type) of continuous type of clinical data, wilcoxon rank sum test (Mann and Whitney, 1947) was applied to compare their mean difference using 'wilcox.test(continuous.clinical ~ as.factor(group), exact=FALSE)' function in R. This test is equivalent to the Mann-Whitney test.
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.